Abstract:A targeted drug delivery system utilizing folic acidconjugated curcumin for selective targeting of MCF‐7 breast cancer cells is illustrated. The system exploits the overexpression of folate receptors on MCF‐7 cells, enabling specific recognition and binding of the folic acidmodified drug carrier. Upon receptor‐mediated endocytosis, the encapsulated curcumin is internalized into the cancer cells, where it is released to exert its therapeutic effects. This selective targeting mechanism enhances the drug's bioavailability and therapeutic efficacy while minimizing potential side effects on healthy cells. The folate receptormediated targeting strategy demonstrates enhanced cellular uptake and cytotoxicity specifically in MCF‐7 breast cancer cells, leading to programmed cell death. This study explores the therapeutic potential of curcumin (CUR) in cancer therapy, specifically examining its targeted transport through folate receptors and its interaction with certain proteins in breast cancer cell lines. We employed molecular docking technique to assess the binding affinities of CUR with proteins 1H1Q, 1UOM, 4JDD, 5U2D and MCF10A normal breast epithelial cell line protein 5UGB. Out of these, the CUR–1H1Q complex exhibited the greatest binding affinity. To assess the stability of this complex in a biological setting, we conducted molecular dynamics simulations of the 1H1Q–CUR complex for a duration of 100 ns. The simulations demonstrated an extremely stable Cα‐backbone, exhibiting a consistently low root mean square deviation. The radius of gyration measurements suggested a condensed structure with specific areas of flexibility. The simulation revealed a consistent hydrogen bond between CUR and 1H1Q, indicating a robust and long‐lasting interaction between the two molecules. The results indicate that the cytotoxicity of curcumin on MCF7 cancer cell lines is mainly affected by its interactions with several proteins found in these cancer cells. Among the four proteins tested, 1H1Q has the greatest influence. The high affinity of these proteins for curcumin, which results in the creation of stable complexes, seems to trigger cell death. Curcumin's biocompatibility and toxicological effects were investigated in both normal and cancerous cell lines. The study revealed enhanced biocompatibility and potential toxicity in cancerous cell lines, while demonstrating reduced toxicity in normal cell lines.

Target Profiling of an Anticancer Drug Curcumin by an In Situ Chemical Proteomics Approach

Click Chemistry Approach to Characterize Curcumin-Protein Interactions in Vitro and in Vivo.

Hunting Molecular Targets for Anticancer Reagents by Chemical Proteomics

Proteome interrogation using nanoprobes to identify targets of a cancer-killing molecule.

A Quantitative Chemical Proteomics Approach to Profile the Specific Cellular Targets of Andrographolide, a Promising Anticancer Agent That Suppresses Tumor Metastasis*

In Silico Analysis of Curcumin's Targeted Cancer Therapy: Folate Receptor Pathways and Molecular Interaction Insights

Chemical Proteomic Strategies for the Discovery and Development of Anticancer Drugs

Ancient Drug Curcumin Impedes 26S Proteasome Activity by Direct Inhibition of Dual-Specificity Tyrosine-Regulated Kinase 2

Chemical Proteomics to Identify Molecular Targets of Small Compounds

Chemical Markers' Knockout Coupled with UHPLC-HRMS-based Metabolomics Reveals Anti-Cancer Integration Effects of the Curcuminoids of Turmeric (curcuma Longa L.) on Lung Cancer Cell Line.

Spatial Metabolomics Profiling Reveals Curcumin Induces Metabolic Reprogramming in Three-Dimensional Tumor Spheroids

Target identification of natural medicine with chemical proteomics approach: probe synthesis, target fishing and protein identification

Biochemometric approach combined with 1D CSSF-TOCSY for the identification of sensitization agents in Curcuma longa L. and prediction of their action mechanisms

An immuno-chemo-proteomics method for drug target deconvolution

Application of Ultra-Performance Liquid Chromatography Coupled with Quadrupole Time-of-flight Mass Spectrometry to Identify Curcumin Metabolites Produced by Human Intestinal Bacteria.

Click chemistry-based imaging to study the tissue distribution of the curcumin-protein complex in mice

Functional Drug–target–disease Network Analysis of Gene–phenotype Connectivity for Curcumin in Cancer

Chemical Proteomics: Terra Incognita for Novel Drug Target Profiling

Proteomic Analysis of Anticancer TCMs Targeted at Mitochondria.

Identification of potential pathways involved in the induction of cell cycle arrest and apoptosis by a new 4-arylidene curcumin analogue T63 in lung cancer cells: a comparative proteomic analysis.

Using Photoreactive Probes to Identify Viable Drug Targets in Non-small Cell Lung Cancer